Call Now Open
2026 Oxford-Harrington Rare Disease Scholar Award
January 15, 2026
The Oxford-Harrington Rare Disease Centre (OHC), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, is seeking highly innovative projects for its 2026 Rare Disease Scholar Award, which accelerates promising therapeutics discoveries from academic labs...
Continue Reading
May 01, 2024
Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading
April 16, 2024
10 physician-scientists have been selected for drug development grant to advance discoveries into the clinic Continue Reading
April 01, 2024
Call for proposals focused on proteostasis, senescence, and other novel approaches Continue Reading
March 25, 2024
Nature Chemical Biology, published March 25, 2024 Continue Reading
March 19, 2024
2024 Harrington Prize for Innovation in Medicine Recognizes Pioneering Work in Immunology Continue Reading
March 13, 2024
The rapidly evolving SARS-CoV-2 virus threatens the progress made in curbing the COVID-19 pandemic. A promising novel drug candidate, designed at the atomic level, could help doctors halt the rise of lethal new drug resistant variants. Continue Reading
February 08, 2024
Dr. Paul Tesar of Case Western Reserve University and Dr. Donald F. Weaver of University Health Network selected for their work targeting novel pathways in Alzheimer’s Continue Reading
February 06, 2024
New Scholar Award Accelerates Novel Therapies for Rare Diseases Continue Reading
January 16, 2024
The Jenner Institute is conducting a new study, using BCG, the current licensed vaccine against tuberculosis. Continue Reading
January 03, 2024
Co-founder and president of Harrington Discovery Institute at University Hospitals receives highest professional distinction awarded solely to inventors Continue Reading